APA (7th ed.) Citation

AduQuaye, M., Dube, S., Bashir, B., Chowdhury, A., Ahmed, N., Leylek, A., . . . Rathod, S. (2022). Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy. Current Oncology, 29(1), 193. https://doi.org/10.3390/curroncol29010019

Chicago Style (17th ed.) Citation

AduQuaye, Marina, et al. "Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy." Current Oncology 29, no. 1 (2022): 193. https://doi.org/10.3390/curroncol29010019.

MLA (9th ed.) Citation

AduQuaye, Marina, et al. "Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy." Current Oncology, vol. 29, no. 1, 2022, p. 193, https://doi.org/10.3390/curroncol29010019.